There 3.3 million breast cancer survivors in the United States who have undergone breast implants augmentation surgery. Worldwide, more than 10 million are living with breast implants. In recent years, many complications have been attributed to these implants.
Some women experience implant illness, for which symptoms may include chronic fatigue and other symptoms associated with an autoimmune disease. Other women may have implants that develop a rate type of T-cell non-Hodgkin’s lymphoma around the breast implant. As of 2019, 656 cases of this rare type of lymphoma have been reported, but the actual numbers are believed to be higher. Additionally, 17 deaths have been associated with this condition. In March 2019, the U.S. Food and Drug Administration held a meeting specifically to address the rising concern for breast implant associated complications.